130 related articles for article (PubMed ID: 13367768)
1. The use of reserpine in chronic psychotic patients: a controlled trial.
WING L
J Ment Sci; 1956 Jul; 102(428):530-41. PubMed ID: 13367768
[No Abstract] [Full Text] [Related]
2. Evaluation of reserpine and methyl phenidylacetate used separately and in combination in chronic psychotic patients.
FOX WW; MCPHEETERS H
J Ky State Med Assoc; 1956 Sep; 54(9):785-91. PubMed ID: 13357869
[No Abstract] [Full Text] [Related]
3. Reserpine in hospitalized psychotics; a controlled study on chronically disturbed women.
ARNOLD AL; FREEMAN H
AMA Arch Neurol Psychiatry; 1956 Sep; 76(3):281-5. PubMed ID: 13354049
[No Abstract] [Full Text] [Related]
4. Combined chlorpromazine and reserpine in the treatment of chronic psychotics.
FOOTE ES
J Ment Sci; 1958 Jan; 104(434):201-5. PubMed ID: 13514461
[No Abstract] [Full Text] [Related]
5. The use of chlorpromazine and of serpasil in the treatment of psychotic patients.
LEWIS LF
Caribb Med J; 1956; 18(1-2):51-66. PubMed ID: 13374729
[No Abstract] [Full Text] [Related]
6. Reserpine in acute psychotic states; report of a controlled study.
HICKERSON GX; SWAIN JM; TEMPEY FW
J Nerv Ment Dis; 1956 Dec; 124(6):614-7. PubMed ID: 13476191
[No Abstract] [Full Text] [Related]
7. Reserpine and chronic psychosis: two-year outcome in a treatment group.
FERGUSON RS
J Ment Sci; 1959 Jan; 105(438):251-5. PubMed ID: 13641979
[No Abstract] [Full Text] [Related]
8. Reserpine in chronic psychoses.
FORSTER W; SCHLICHTHER W; HENDERSON AL
Can Med Assoc J; 1955 Dec; 73(12):951-6. PubMed ID: 13276884
[No Abstract] [Full Text] [Related]
9. Rauwolfia alkaloids and reserpine in the treatment of the chronic psychotic patient.
ELKES C
J Ment Sci; 1957 Jul; 103(432):464-74. PubMed ID: 13449556
[No Abstract] [Full Text] [Related]
10. Controlled study on clinical use of reserpine in psychotic patients with special comments on sources of error.
SCHRUT AH
J Nerv Ment Dis; 1955 Dec; 122(6):513-7. PubMed ID: 13332427
[No Abstract] [Full Text] [Related]
11. [Clinical trial with serpasil in psychoses].
LIDVALL HF
Sven Lakartidn; 1956 Jul; 53(27):1729-32. PubMed ID: 13352257
[No Abstract] [Full Text] [Related]
12. Use of reserpine (serpasil) in psychotic patients; a preliminary report.
WEISHAUS J
Dis Nerv Syst; 1955 Nov; 16(11):347-50. PubMed ID: 13270677
[No Abstract] [Full Text] [Related]
13. [Results and considerations on the use of reserpine in the treatment of psychoses].
FAZIO C
Arch Psicol Neurol Psichiatr; 1956; 17(2-3):313-5. PubMed ID: 13341400
[No Abstract] [Full Text] [Related]
14. Use of reserpine in chronic non-disturbed psychotics.
BOUDWIN J; KLINE NS
Psychiatr Res Rep Am Psychiatr Assoc; 1956 Apr; (4):71-8. PubMed ID: 13323114
[No Abstract] [Full Text] [Related]
15. A comparison between combined reserpine-chlorpromazine and chlorpromazine therapies in psychiatry.
HORMIA A
Acta Psychiatr Neurol Scand; 1956; 31(4):437-46. PubMed ID: 13381524
[No Abstract] [Full Text] [Related]
16. Physiological studies after continuous serpasil therapy over 18 months.
FOGEL EJ
Dis Nerv Syst; 1956 Oct; 17(10):322-3. PubMed ID: 13365515
[No Abstract] [Full Text] [Related]
17. The place of reserpine in the treatment of the chronic psychotic patient.
GORE CP; EGAN GP; WALTON D
Am J Psychiatry; 1957 Oct; 114(4):333-7. PubMed ID: 13458497
[No Abstract] [Full Text] [Related]
18. 17-Hydrocorticosteroid levels in the peripheral blood of psychotic patients under treatment with chlorpromazine and reserpine; a preliminary study.
TUI C; RILEY E; ORR A
J Clin Exp Psychopathol; 1956; 17(2):142-6. PubMed ID: 13345876
[No Abstract] [Full Text] [Related]
19. Effects of tranquilizers upon pathological activity in psychotic patients.
CUTLER RP; MONROE JJ; ANDERSON TE
AMA Arch Neurol Psychiatry; 1957 Jul; 78(1):61-8. PubMed ID: 13434527
[No Abstract] [Full Text] [Related]
20. [Reserpine in acute psychosis].
ROSINA PL
Arch Psicol Neurol Psichiatr; 1956; 17(2-3):417. PubMed ID: 13341411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
